NCT06494046 2025-06-04
Defining Musical Toxicity and Its Effect on Patient Well-being
Mayo Clinic
Withdrawn
Clinical Trials
9 trialsNCT05840770 2025-05-26
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
City of Hope Medical Center
Phase 2 Withdrawn
NCT06075615 2025-02-07
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.
Pfizer
Withdrawn
NCT05999357 2024-05-29
STRIDER
Maastricht University Medical Center
Phase 2 Withdrawn
NCT04650490 2023-03-02
STICk-IM-NSCLC
Duke University
Phase 2 Withdrawn
NCT02014545 2018-07-05
Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT01913067 2014-07-24
CRANIAL
Jules Bordet Institute
Phase 2 Withdrawn
NCT00738335 2012-10-04
Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases
University of California, San Francisco
Phase 1 Withdrawn